Compare Preoperative Visual Outcomes Obtained With the VirtIOL Device With Postoperative Results in PRELEX Patients.
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT04037631|
Recruitment Status : Recruiting
First Posted : July 30, 2019
Last Update Posted : July 30, 2019
|Condition or disease||Intervention/treatment|
|Presbyopia||Device: AT LISA tri 839MP|
|Study Type :||Observational|
|Estimated Enrollment :||100 participants|
|Official Title:||Prospective Clinical Study to Compare Preoperative Visual Performance Criteria Obtained With the VirtIOL Device With Postoperative Results in PRELEX Patients.|
|Actual Study Start Date :||July 20, 2017|
|Estimated Primary Completion Date :||August 31, 2021|
|Estimated Study Completion Date :||August 31, 2021|
Device: AT LISA tri 839MP
Implantation of AT LISA tri 839MP intraocular lens in one eye
- Corrected distance visual acuity (CDVA) [ Time Frame: 3 months after surgery ]Evaluation of preoperative CDVA obtained with VirtIOL device compared to postoperative CDVA.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04037631
|Contact: Gergana Fullefirstname.lastname@example.org|
|Internationale Innovative Ophthalmologie||Recruiting|
|Düsseldorf, Germany, 40549|
|Contact: Hakan Kaymak 0211 586757-0|